RFG
TMO icon

REAP Financial Group’s Thermo Fisher Scientific TMO Stock Holding History

REAP Financial Group’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$61.3K Sell
122
-5
-4% -$2.4K 0.01% 271
2026
Q1 		$62.5K Buy
127
+2
+2% +$1.08K 0.01% 260
2025
Q4 		$72.5K Buy
125
+17
+16% +$9.61K 0.01% 246
2025
Q3 		$52.4K Buy
108
+4
+4% +$1.86K 0.01% 263
2025
Q2 		$42.2K Buy
104
+59
+131% +$24.7K 0.01% 282
2025
Q1 		$22.4K Buy
45
+24
+114% +$13K 0.01% 298
2024
Q4 		$10.9K Sell
21
-19
-48% -$10.4K ﹤0.01% 359
2024
Q3 		$24.8K Buy
40
+20
+100% +$11.8K 0.01% 248
2024
Q2 		$11.1K Sell
20
-2
-9% -$1.15K ﹤0.01% 326
2024
Q1 		$12.8K Buy
22
+1
+5% +$561 ﹤0.01% 344
2023
Q4 		$11.2K Buy
+21
New +$10.2K ﹤0.01% 381

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

REAP Financial Group's TMO Position: Q2 2026 in Review

REAP Financial Group reduced its Thermo Fisher Scientific (TMO) stake by 3.9% in Q2 2026, selling an estimated $2.4K and leaving 122 shares worth $61.3K. The position accounts for 0.01% of the portfolio, ranked #271.

REAP Financial Group first reported a position in TMO in Q4 2023 and has held it in 11 quarters since. The position peaked at $72.5K in Q4 2025. 2,615 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • REAP Financial Group held 122 shares of Thermo Fisher Scientific worth $61.3K as of Q2 2026.
  • REAP Financial Group sold 5 Thermo Fisher Scientific shares in Q2 2026, an estimated $2.4K.
  • Thermo Fisher Scientific made up 0.01% of REAP Financial Group's portfolio in Q2 2026, its #271 holding.
  • REAP Financial Group first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 11 quarters since.
  • REAP Financial Group's Thermo Fisher Scientific position peaked at $72.5K in Q4 2025.
  • 2,615 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on REAP Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.